Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry Study for Personalized Cancer Therapy

NCT02508662 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT02508662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02508662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry Study for Personalized Cancer Therapy
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Completed
Start date
July 21, 2015
Completion date
July 10, 2020
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancers, solid tumors